The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-1920
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Correction: The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer

Clinical Cancer Research
Cancer ResearchOncology
2017English

Chimeric Antigen Receptors for T Cell Immunotherapy: Current Understanding and Future Directions

Journal of Gene Medicine
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2012English

New Targeted Molecular Therapies for Dedifferentiated Thyroid Cancer

Journal of Oncology
Oncology
2010English

Pcn301 - Health Technology Assessment for Chimeric Antigen Receptor (Car) T-Cell Therapies for Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

214. Design of Multifunctional Chimeric Antigen Receptors for T Cell Cancer Immunotherapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Chimeric Antigen Receptor T Cell Therapies for Multiple Myeloma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

The Other Face of Chimeric Antigen Receptors

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Targeted Therapies for Pancreatic Cancer

Cancers
Cancer ResearchOncology
2018English

Targeted Cancer Therapies

Chinese Journal of Cancer
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy